Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study

Author:

Wang Tiange12ORCID,Li Mian12ORCID,Zeng Tianshu3ORCID,Hu Ruying4,Xu Yu12,Xu Min12ORCID,Zhao Zhiyun12,Chen Yuhong12ORCID,Wang Shuangyuan12,Lin Hong12,Yu Xuefeng5ORCID,Chen Gang6ORCID,Su Qing7,Mu Yiming8ORCID,Chen Lulu3ORCID,Tang Xulei9,Yan Li10ORCID,Qin Guijun11ORCID,Wan Qin12,Gao Zhengnan13,Wang Guixia14ORCID,Shen Feixia15,Luo Zuojie16ORCID,Qin Yingfen16ORCID,Chen Li17ORCID,Huo Yanan18,Li Qiang19,Ye Zhen4,Zhang Yinfei20,Liu Chao21,Wang Youmin22,Wu Shengli23,Yang Tao24ORCID,Deng Huacong25,Zhao Jiajun26,Shi Lixin27ORCID,Ning Guang12ORCID,Bi Yufang12ORCID,Wang Weiqing12ORCID,Lu Jieli12ORCID

Affiliation:

1. 1Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2. 2Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine and Metabolic Diseases, State Key Laboratory for Endocrine Tumor, State Key Laboratory for Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

3. 3Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

4. 4Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

5. 5Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

6. 6Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China

7. 7Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

8. 8Chinese People’s Liberation Army General Hospital, Beijing, China

9. 9The First Hospital of Lanzhou University, Lanzhou, China

10. 10Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

11. 11The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

12. 12The Affiliated Hospital of Southwest Medical University, Luzhou, China

13. 13Dalian Municipal Central Hospital, Dalian, China

14. 14The First Hospital of Jilin University, Changchun, China

15. 15The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

16. 16The First Affiliated Hospital of Guangxi Medical University, Nanning, China

17. 17Qilu Hospital of Shandong University, Jinan, China

18. 18Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, China

19. 19The Second Affiliated Hospital of Harbin Medical University, Harbin, China

20. 20Central Hospital of Shanghai Jiading District, Shanghai, China

21. 21Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China

22. 22The First Affiliated Hospital of Anhui Medical University, Hefei, China

23. 23Karamay Municipal People’s Hospital, Xinjiang, China

24. 24The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

25. 25The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

26. 26Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China

27. 27Affiliated Hospital of Guiyang Medical College, Guiyang, China

Abstract

OBJECTIVE To investigate whether the association between insulin resistance and cardiovascular disease (CVD) differs by glucose tolerance status. RESEARCH DESIGN AND METHODS We analyzed a nationwide sample of 111,576 adults without CVD at baseline, using data from the China Cardiometabolic Disease and Cancer Cohort Study. Insulin resistance was estimated by sex-specific HOMA of insulin resistance (HOMA-IR) quartiles for participants with normal glucose tolerance, prediabetes, or diabetes, separately, and by 1 SD of HOMA-IR for the overall study participants. We used Cox proportional hazards models to examine the association between insulin resistance and incident CVD according to glucose tolerance status and evaluate the CVD risk associated with the combined categories of insulin resistance and obesity in prediabetes and diabetes, as compared with normal glucose tolerance. Models were adjusted for age, sex, education attainment, alcohol drinking, smoking, physical activity, and diet quality. RESULTS In participants with normal glucose tolerance, prediabetes, and diabetes defined by three glucose parameters, multivariable-adjusted hazard ratios (95% CIs) for incident CVD associated with the highest versus the lowest quartile of HOMA-IR were 1.03 (0.82–1.30), 1.23 (1.07–1.42), and 1.61 (1.30–2.00), respectively; the corresponding values for CVD per 1-SD increase in HOMA-IR were 1.04 (0.92–1.18), 1.12 (1.06–1.18), and 1.15 (1.09–1.21), respectively (P for interaction = 0.011). Compared with participants with normal glucose tolerance, in participants with prediabetes, the combination of the highest HOMA-IR quartile and obesity showed 17% (95% CI 2–34%) higher risk of CVD, while the combination of the lowest two HOMA-IR quartiles and nonobesity showed 15–17% lower risk of CVD. In participants with diabetes, the upper two HOMA-IR quartiles exhibited 44–77% higher risk of CVD, regardless of obesity status. Consistent findings were observed for glucose tolerance status defined by different combinations of glycemic parameters. CONCLUSIONS Glucose intolerance status exacerbated the association between insulin resistance and CVD risk. Compared with adults with normal glucose tolerance, adults with prediabetes who were both insulin resistant and obese exhibited higher risks of CVD, while in adults with diabetes, the CVD risk related to insulin resistance remained, regardless of obesity.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3